kras mutation and glutathion glynac G12 mutant alleles differentially control glutamine metabolism via FOXO1 Targeting KRAS: from metabolic regulation
Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy Molecular Cancer Springer Nature Link Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell KRAS Targeted Therapy Doubles as Component of Immunotherapy NCI
Pay in 4 interest-free payments of $7.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27



